March 18, 2026 19:34 ET | Source: Vaxcyte, Inc. Based on the Strength of Unprecedented Results from the Positive Phase…
Beyfortus study published in The Lancet Infectious Diseases shows benefit for infants beyond first RSV season First study showing that…
— First randomized Phase III trial confirming the efficacy of MET inhibition in patients with advanced NSCLC and acquired MET…